NCT05332795View on ClinicalTrials.gov

The Impact of Metformin on the Outcome of Gouty Arthritis in a Cohort of Egyptian Gouty Patients.

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

February 20, 2024

Conditions
Gouty Arthritis
Interventions
DRUG

Metformin

gouty patients, will receive metformin tablets (1000 mg) once daily for about 3 months.

DRUG

Placebo

gouty patients, will receive placebo tablets once daily for about 3 months.

Trial Locations (1)

123455

Dalia Salah Saif, Menoufia Governorate

All Listed Sponsors
lead

Menoufia University

OTHER